Skip to content

CROSSLEAD Penetration CLP01430SRecalls & reported problems

Asahi Intecc CO., Ltd. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04547327143875), received between Aug 18, 2025 and Aug 27, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Fragmentation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 2 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Fragmentation1
  • Material Separation1

Patient problems

  • Foreign Body In Patient1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 27, 2025Material Separation; Material Separation

    IT WAS REPORTED THAT AN ENDOVASCULAR TREATMENT (EVT) WAS PERFORMED FOR A HEAVILY CALCIFIED AND MILDLY FLEXUOUS CHRONIC TOTAL OCCLUSIONS (CTO) FOR THE SECOND TIME AS THE PAST PROCEDURE HAD FAILED. WHEN AN ASAHI CROSSLEAD PENETRATION GUIDE WIRE WAS ANTEGRADELY MANIPULATED, THE DISTAL SEGMENT OF THE GUIDE WIRE GOT FRACTURED. THE WIRE FRAGMENT WAS LEFT IN SITU, AND THE PROCEDURE WAS FINISHED. IT WAS REPORTED THAT THE PHYSICIAN SUGGESTED A BYPASS SURGERY FOR REVASCULARIZATION TO THE PATIENT.

    Patient problems: Foreign Body In Patient

    MAUDE report 22901776 ↗
  • MalfunctionAug 18, 2025Material Fragmentation; Material Fragmentation

    WHILE TORQUING WIRE IN CALCIFIED A.T. DISTAL TIP OF WIRE CAME OFF. LEFT IN PATIENT, NO INJURY BUT HAVE DEVICE TO RETURN. RETURNING WIRE - WAS IN BODY AND NOT RESTERILIZED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22833370 ↗

Other Wire, guide, catheter devices

All Wire, guide, catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page